Abstract
Antibodies against SARS-CoV-2 are critical molecules of the efforts to understand and fight the COVID-19 Pandemic. They play a central role in clearing the virus from infected patients. They are key reagents of rapid diagnostics. They are first-line treatments for hospitalized COVID-19 patients and are the main objective of COVID-19 vaccine development. The vaccines and therapeutic antibo…